Table 4.

Rate of change in eGFR by age and eGFR at baseline

Baseline eGFR (ml/min per 1.73 m2)Age Group% with Annual eGFR Decrement >3 ml/min per 1.73 m2Adjusted Oddsa of Annual Decrement in eGFR >3 ml/min per 1.73 m2
45 to 59 (n = 117,922)18 to 4416.621.00 (referent)
45 to 5421.931.23 (1.02 to 1.47)
55 to 6422.951.23 (1.30 to 1.47)
65 to 7425.071.28 (1.08 to 1.53)
75 to 8428.001.48 (1.24 to 1.76)
85 to 10034.102.00 (1.67 to 2.41)
30 to 44 (n = 57,339)18 to 4445.871.00 (referent)
45 to 5435.300.57 (0.45 to 0.72)
55 to 6429.900.43 (0.34 to 0.54)
65 to 7425.410.33 (0.27 to 0.41)
75 to 8424.300.33 (0.27 to 0.42)
85 to 10026.030.39 (0.31 to 0.49)
15 to 29 (n = 15,694)18 to 4452.511.00 (referent)
45 to 5448.900.81 (0.58 to 1.12)
55 to 6444.330.67 (0.49 to 0.93)
65 to 7434.120.46 (0.34 to 0.63)
75 to 8426.700.36 (0.26 to 0.49)
85 to 10024.910.35 (0.25 to 0.49)
<15 (n = 1768)18 to 4446.941.00 (referent)
45 to 5449.801.19 (0.64 to 2.23)
55 to 6443.030.92 (0.49 to 1.71)
65 to 7436.850.74 (0.40 to 1.36)
75 to 8436.470.76 (0.41 to 1.41)
85 to 10026.390.50 (0.23 to 1.10)
  • a Adjusted for race, gender, diabetes, coronary artery disease, peripheral arterial disease, congestive heart failure, cerebrovascular disease, and Charlson score.